Impact of expanding access to continuous glucose monitoring systems among insulin users with type 1 or type 2 diabetes
Pathak S, Kearin K, Kahkoska A et al.
Diabetes Technol Ther. Pub. online 8 Dec 2022.
Leggi
Breaking news
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Battelino T, Alexander CM, Amiel SA, et al.
The Lancet Diabetes and Endocrinology. Pub. online, 6 December 2022.
Leggi
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy
Maalmi H, Strom A, Petrera A, et al.
Diabetologia. Pub. online 6 Dec 2022.
Leggi
Initiation of sodium-glucose cotransporter-2 inhibitors at lower HbA1c threshold attenuates eGFR decline in type 2 diabetes patients with and without cardiorenal disease: A propensity-matched cohort study
Cheung JTK, Yang A, Wu H, et al.
Diabetes Res Clin Pract. Pub. online 6 Dec 2022.
Leggi
Two decades of diabetes prevention efforts: a call to innovate and revitalize our approach to lifestyle change
Golovaty I, Ritchie ND, Tuomilehto J, et al.
Diabetes Res Clin Pract. 2022;110195.
Leggi
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Urva S, Coskun T, Loh MT, et al.
Lancet. 2022;400(10366):1869-1881.
Leggi
Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering
Mistry S, Gouripeddi R, Raman V, Facelli JC
Diabetologia. 2022 Nov 30.
Leggi
Comparison of sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist prescribing in patients with diabetes mellitus with and without cardiovascular disease
Gay HC, Yu J, Persell SD, et al.
Am J Cardiol. 2022;S0002-9149(22)01131-6.
Leggi
Fully closed-loop insulin delivery in patients undergoing pancreatic surgery
Krutkyte G, Roos J, Schuerch D, et al.
Diabetes Technol Ther. 2022 Nov 30.
Leggi
KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease
Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group
Kidney Int. 2022;102(5S):S1-S127.
Leggi